SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION vs CAC Software

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

by DIACOUSTIC MEDICAL DEVICES (PTY)

CAC Software

by Imbio

AI Verdict

These tools are adjacent in their application within cardiology, but not direct competitors. SENSICARDIAC MOBI focuses on diagnosing heart murmurs by analyzing acoustic heart signals, aiding physicians in differentiating sound types. In contrast, Imbio's CAC Software quantifies coronary artery calcification from CT scans to assess atherosclerotic plaque burden, providing different diagnostic insights for cardiovascular risk assessment.

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if…

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if you need an immediate, AI-assisted assessment of heart murmurs during a patient encounter. This mobile application is ideal for physicians using an electronic stethoscope to quickly differentiate between physiological and pathological heart sounds, aiding in early diagnosis and referral decisions.

View SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION →

Choose CAC Software if…

Choose Imbio's CAC Software if you require automated, quantitative analysis of coronary artery calcification from non-contrast chest CT scans. This tool is best suited for radiologists and cardiologists seeking to assess a patient's cardiovascular risk by accurately measuring calcified lesion mass, volume, and Agatston score.

View CAC Software →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	CAC Software
Pricing	Contact for pricing	Contact for pricing
Deployment	Hosted server environment (Linux OS) with a mobile application interface	Cloud, On-premise, Partner platforms
BAA Available	Yes AI-estimated	Unknown
FDA Status	1 AI-estimated	1 AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CAC Software

Tool B integrates seamlessly into existing DICOM viewing workflows, minimizing disruption for radiologists and cardiologists by leveraging familiar interfaces. In contrast, Tool A, while mobile, requires a separate application and a user-provided electronic stethoscope, which could introduce additional setup and workflow changes.

Clinical Value

Tie

Both tools are FDA-cleared and offer significant, distinct clinical value in cardiac care. Tool A provides real-time diagnostic support for heart murmurs at the point of care, aiding in early detection and referral. Tool B offers crucial quantitative risk assessment for coronary artery disease from CT scans, supporting prognostic evaluation and preventative strategies.

Pricing & Value

Tie

Neither tool provides publicly available pricing information, making a direct comparison of their cost-effectiveness or overall value proposition impossible. Both require direct contact with the vendor for pricing details, which limits transparency.

Enterprise Readiness

CAC Software

Tool B offers superior enterprise readiness with flexible deployment options including cloud, on-premise, and partner platforms, accommodating diverse IT infrastructures and security preferences. Tool A's reliance on a hosted server environment with a mobile interface presents a more limited and potentially less adaptable deployment model for large organizations.

Innovation

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

Tool A demonstrates a slightly higher degree of innovation by applying AI to real-time acoustic analysis on a mobile platform, directly augmenting a traditional physical examination at the point of care. While Tool B's deep-learning based image analysis for quantitative CAC is also highly innovative, Tool A's approach to a common diagnostic challenge feels more disruptive in its method of delivery and direct interaction with the patient encounter.

Support & Docs

CAC Software

Imbio (Tool B) demonstrates a more established and transparent support framework, offering multiple contact channels and indicating the availability of user manuals and product documentation upon request. In contrast, public information regarding specific support resources or documentation for SensiCardiac Mobi (Tool A) is not readily available, suggesting a less formalized public-facing support structure.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	CAC Software
Tool Name	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	CAC Software
Company	DIACOUSTIC MEDICAL DEVICES (PTY)	Imbio
Primary Purpose	Assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope to differentiate between physiological and pathological sounds.	Automated image post-processing algorithms designed to help radiologists and cardiologists determine the location and calculate the amount of calcification within the coronary arteries in patients who have undergone a non-contrast, chest computed tomography (CT).
Input Data Type	Acoustic heart signals from an electronic stethoscope	Non-contrast, chest computed tomography (CT) images
Output/Analysis Provided	Distinguishes between normal/physiological and pathological heart murmurs; identifies S1, S2, and suspected murmurs; operates as decision support software.	Quantification of calcification (Agatston score, arterial age, calcified lesion mass and volume); 3D visualizations and annotated images; supports risk assessment for coronary artery disease.
Specialties	Cardiology, Internal Medicine, Pediatrics	Cardiology, Radiology

Videos

Demos, reviews, and walkthroughs featuring SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION and CAC Software.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How does each tool integrate into a physician's existing clinical workflow, and what is its primary clinical impact?

SensiCardiac Mobi directly aids in real-time auscultation by analyzing heart sounds from an electronic stethoscope on a mobile device, enhancing the physician's ability to differentiate between physiological and pathological murmurs. Imbio CAC Software integrates into the existing DICOM viewing workflow, providing automated quantification of coronary artery calcification from non-contrast chest CT scans to support cardiovascular risk assessment.

What level of integration can be expected with electronic health record (EHR) systems for the output generated by each tool?

SensiCardiac Mobi, being a mobile application, captures patient data and records acoustic heart signals, which would likely require specific integration pathways or manual input to transfer results into the EHR. Imbio CAC Software outputs DICOM-formatted images and PDF reports that are typically read at a PACS workstation, suggesting a more streamlined process for incorporating its quantitative scores and annotated images directly into patient records and the EHR.

For which specific medical specialties and clinical use cases is each tool best suited?

SensiCardiac Mobi is designed for cardiology, internal medicine, and pediatrics, primarily to assist in the early detection and differentiation of heart murmurs during physical examinations. Imbio CAC Software targets cardiology and radiology, providing automated analysis of non-contrast chest CTs to quantify coronary artery calcification for cardiovascular risk stratification.

How do the underlying AI algorithms contribute to the accuracy and reliability of each tool's findings?

SensiCardiac Mobi utilizes an AI-powered algorithm to analyze acoustic heart signals, aiming to accurately distinguish between normal/physiological and pathological heart murmurs. Imbio CAC Software employs deep-learning based automated image post-processing algorithms to precisely quantify coronary artery calcification, providing objective and standardized measurements like the Agatston score.

What is the anticipated learning curve for physicians to become proficient with each tool, and how quickly can clinical value be realized?

SensiCardiac Mobi leverages a familiar auscultation process with a mobile interface, suggesting a relatively low learning curve for physicians already using electronic stethoscopes, with immediate value in enhanced murmur detection. Imbio CAC Software integrates into existing imaging review workflows, allowing radiologists and cardiologists to quickly incorporate automated CAC quantification into their routine, providing rapid value in risk assessment.

What features are available for tracking the use of each tool and the origin of its generated data or analysis?

SensiCardiac Mobi acquires and records acoustic heart signals and their analysis, providing a record of the assessment performed. Imbio CAC Software generates specific outputs like Agatston scores, 3D visualizations, and annotated images, creating a clear trail of the automated analysis applied to a patient's CT scan, often in DICOM or PDF summary reports.

What are the primary considerations for implementing each tool across multiple clinical sites within a healthcare system?

For SensiCardiac Mobi, multi-site rollout would involve distributing the mobile application, ensuring compatible electronic stethoscopes are available, and standardizing training for its use in auscultation. Imbio CAC Software would require integration with the existing DICOM viewing workflows and PACS systems across various sites, ensuring consistent access to its automated image analysis capabilities, with options for cloud or on-premise deployment.